MDMA-like behavioral effects of N-substituted piperazines in the mouse
- PMID: 17651790
- PMCID: PMC2082056
- DOI: 10.1016/j.pbb.2007.06.007
MDMA-like behavioral effects of N-substituted piperazines in the mouse
Abstract
Few studies have characterized the subjective effects of N-substituted piperazines, but these drugs show potential for abuse in humans, and have often been associated with MDMA ("ecstasy") in this regard. The aim of the present study was to test the capacity of N-substituted piperazines to induce a head twitch response, alter locomotor activity, and induce MDMA-like discriminative stimulus effects in mice. Various doses of l-benzylpiperazine (BZP), 1-(3-trifluoromethylphenyl) piperazine (TFMPP), 1-(3-methoxybenzyl) piperazine (m-MeO-BZP) or meta-chlorophenyl piperazine (m-CPP) were administered to mice to determine the effects on these behavioral endpoints. BZP, but not its meta-methoxyl analogue, increased locomotor activity in a dose-dependent manner; the phenylpiperazines and m-MeO-BZP only decreased locomotor activity. TFMPP was the only compound active in the head twitch assay, eliciting a moderate head twitch response which was comparable to that previously observed with the MDMA enantiomers. BZP, TFMPP and m-CPP fully substituted in S(+)-MDMA-trained animals, but did not elicit significant drug lever responding in mice trained to discriminate R(-)-MDMA. m-MeO-BZP partially substituted for both training drugs. The present results suggest that BZP has stimulant-like effects, and that TFMPP has hallucinogen-like effects. Their structural analogues, however, do not share these behavioral profiles. Further studies into the relationships between the N-substituted piperazines and MDMA are warranted.
Figures





Similar articles
-
N-substituted piperazines abused by humans mimic the molecular mechanism of 3,4-methylenedioxymethamphetamine (MDMA, or 'Ecstasy').Neuropsychopharmacology. 2005 Mar;30(3):550-60. doi: 10.1038/sj.npp.1300585. Neuropsychopharmacology. 2005. PMID: 15496938
-
Effects of "Legal X" piperazine analogs on dopamine and serotonin release in rat brain.Ann N Y Acad Sci. 2004 Oct;1025:189-97. doi: 10.1196/annals.1316.024. Ann N Y Acad Sci. 2004. PMID: 15542717
-
Locomotor and discriminative stimulus effects of four novel hallucinogens in rodents.Behav Pharmacol. 2017 Aug;28(5):375-385. doi: 10.1097/FBP.0000000000000309. Behav Pharmacol. 2017. PMID: 28537942 Free PMC article.
-
Benzylpiperazine: "A messy drug".Drug Alcohol Depend. 2016 Jul 1;164:1-7. doi: 10.1016/j.drugalcdep.2016.04.010. Epub 2016 May 6. Drug Alcohol Depend. 2016. PMID: 27207154 Review.
-
Subjective effects in humans following administration of party pill drugs BZP and TFMPP alone and in combination.Drug Test Anal. 2011 Sep;3(9):582-5. doi: 10.1002/dta.285. Epub 2011 Apr 28. Drug Test Anal. 2011. PMID: 21538945 Review.
Cited by
-
Effects of histamine H(3) receptor activation on the behavioral-stimulant effects of methamphetamine and cocaine in mice and squirrel monkeys.Pharmacology. 2009;83(3):164-9. doi: 10.1159/000191473. Epub 2009 Jan 15. Pharmacology. 2009. PMID: 19145102 Free PMC article.
-
The adrenergic receptor antagonist carvedilol interacts with serotonin 2A receptors both in vitro and in vivo.Pharmacol Biochem Behav. 2019 Jun;181:37-45. doi: 10.1016/j.pbb.2019.04.003. Epub 2019 Apr 15. Pharmacol Biochem Behav. 2019. PMID: 30998954 Free PMC article.
-
Pharmacology of stimulants prohibited by the World Anti-Doping Agency (WADA).Br J Pharmacol. 2008 Jun;154(3):606-22. doi: 10.1038/bjp.2008.124. Br J Pharmacol. 2008. PMID: 18500382 Free PMC article. Review.
-
Effect of Hallucinogens on Unconditioned Behavior.Curr Top Behav Neurosci. 2018;36:159-199. doi: 10.1007/7854_2016_466. Curr Top Behav Neurosci. 2018. PMID: 28224459 Free PMC article. Review.
-
Investigation of the effects of 'piperazine-containing party pills' and dexamphetamine on interhemispheric communication using electroencephalography.Psychopharmacology (Berl). 2016 Aug;233(15-16):2869-77. doi: 10.1007/s00213-016-4335-5. Epub 2016 Jun 11. Psychopharmacology (Berl). 2016. PMID: 27289365 Clinical Trial.
References
-
- Baumann MH, Clark RD, Budzynski AG, Partilla JS, Blough BE, Rothman RB. N-substituted piperazines abused by humans mimic the molecular mechanism of 3,4-methylenedioxymethamphetamine (MDMA, or ‘Ecstasy’) Neuropsychopharmacology. 2005;30:550–560. - PubMed
-
- Benkelfat C, Murphy DL, Hill JL, George DT, Nutt D, Linnoila M. Ethanol-like properties of the serotonergic partial agonist m-chlorophenylpiperazine in chronic alcoholic patients. Arch Gen Psychiat. 1991;48:383. - PubMed
-
- Buydens-Branchey L, Branchey M, Fergeson P, Hudson J, McKernin C. The meta-chlorophenylpiperazine challenge test in cocaine addicts: hormonal and psychological responses. Biol Psychiat. 1997;41:1071–1086. - PubMed
-
- Colpaert FC, Janssen PAJ. The head twitch response to intraperitoneal injection of 5-hydroxytryptophan in the rat: Antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenperone, an LSD antagonist. Neuropharmacology. 1983;22(8):993–1000. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical